Peer Review History

Original SubmissionFebruary 9, 2024
Decision Letter - Dahua Yu, Editor

PONE-D-23-36707Effectiveness of mindfulness-based online therapy or internet-delivered cognitive behavioral therapy compared to treatment as usual among patients with persistent somatic symptoms: Protocol for a randomized controlled trial

PLOS ONE

Dear Dr. Vangelova-Korpinen,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 15 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Dahua Yu

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following in the Acknowledgments Section of your manuscript:

“Funding

This work is supported by European Union's Horizon Europe research and innovation programme (Long Covid HEU Grant no. 101057553 2022-2026) and State Research Funds. The funding sources have no other role in the study.”

We note that you have provided funding information that is currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

“This work is supported by European Union's Horizon Europe research and innovation programme (Long Covid HEU Grant no. 101057553 2022-2026) and State REsearch Funds. The funding sources have no other role in the study.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

3. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process.

4. Please ensure that you refer to Figure 1 in your text as, if accepted, production will need this reference to link the reader to the figure.

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Yes

Reviewer #2: Partly

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: In this study protocol, a three-arm randomized control trial is being proposed which aims to investigate the effectiveness of a mindfulness-based amygdala and insula retraining online program, an internet delivered therapist assisted therapy in addition to standard therapy, and standard treatment alone. Functional ability and quality of life surveys will be collected from participants at baseline 3, 6, and 12 months. Total target accrual is 360.

Minor revisions:

1- Line 277: Consider replacing “numbers” with “counts”.

2- Line 281: Indicate the type of underlying covariance structure that will be used in the linear mixed model or the criteria for selecting it.

3- Identify the software that will be used for statistical analysis.

Reviewer #2: The study accessed the efficacy of online interventions on overcoming the central sensitization of the brain in patients with persistent somatic symptoms. They found that the online programs may improve patients’ enablement.

Overall, the manuscript deals with an interest research topic. The current version of manuscript can be improved by considering the comments below.

1.The authors should illustrate the central sensitization of the brain and how the online interventions overcome central sensitization in detail.

2.The study included 360 participants. Dose participant heterogeneity have an impact on the results. For example, age/gender?

3.In the section of the Statistical Analysis, the specific statistical method should be provided.

4.The framework of the paper needs to be readjusted. The discussion part is the fifth part, but there are no 1-4 in the manuscript. Additionally, the paper lack results section.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Dear Editor, Reviewer#1 and Reviewer 2,

Thank you for your valuable comments. We have made a concerted effort to adequately respond to each comment and suggestion received from the reviewers. We hope that our efforts have improved the manuscript to meet your high standards and make it acceptable for publication in PLOS ONE. We have provided a separate file ('Response to reviewers') with point-by-point responses in a table. Below we provide the same comments in order.

EDITOR COMMENT:

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming.

RESPONSE:

Thank you for this kind note.

We have checked the style guide and made corrections to the following naming of files/captions.

Fig 1. SPIRIT schedule of enrollment, interventions and assessments

Fig 2. Study design

S1. File. SPIRIT 2013 Checklist

S2 Appendix. Diagnostic criteria

S2 Appendix. Power Analysis

S4 Protocol Approved by Ethics Committee (English)

S5 Ethical Statement (HUS22392021)

EDITOR COMMENT:

We note that you have provided funding information that is currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

“This work is supported by European Union's Horizon Europe research and innovation programme (Long Covid HEU Grant no. 101057553 2022-2026) and State REsearch Funds. The funding sources have no other role in the study.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

RESPONSE:

Thank you for noticing this. We have removed funding information from the manuscript and mention it now in the cover letter:

‘This work is supported by European Union's Horizon Europe Research and Innovation Programme (Long Covid, EU Grant no. 101057553 2022-2026) and State Research Funds. The funding sources have no other role in the study.’

Please ensure that it will be mentioned in the Funding Statement section.

EDITOR COMMENT:

When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process.

RESPONSE:

Thank you for pointing out these details.

Below is our revised data availability statement:

Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.

EDITOR COMMENT:

Please ensure that you refer to Figure 1 in your text as, if accepted, production will need this reference to link the reader to the figure.

RESPONSE:Thank you for noticing this. Please see addition on line 185.

EDITOR COMMENT:

Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly

RESPONSE:

Please see amendments for the first comment above. We have now included captions for our supporting information at the end of the manuscript and updated our in-text citations.

REVIEWER COMMENTS

REVIEWER#1

COMMENT:

1- Line 277: Consider replacing “numbers” with “counts”.

RESPONSE:

Thank you for this suggestion. We have changed the wording. Please see line 299

COMMENT:

2- Line 281: Indicate the type of underlying covariance structure that will be used in the linear mixed model or the criteria for selecting it

RESPONSE:

Thank you for helping us clarify and update our analysis plan.

The most suitable correlation structure will be determined from the data based on multiple measures, including Akaike’s and Bayesian Information Criteria. This is now included in our updated data analysis plan, please see lines 301-308.

COMMENT:

3- Identify the software that will be used for statistical analysis.

RESPONSE:

The statistical analyses will be carried out using R statistical computing environment. Please see lines 309-310.

REVIEWER#2

COMMENT:

The authors should illustrate the central sensitization of the brain and how the online interventions overcome central sensitization in detail

RESPONSE:

Thank you for this comment and the opportunity to further clarify these entities.

Please see the following additions:

lines 67-71: These predisposing, triggering and maintaining factors lead to structural, functional and chemical changes in the central nervous system causing alterations in processing of internal and external stimuli, i.e. central sensitization. The mechanisms of central sensitization have been widely studied among patients with chronic pain

lines 144-145: Meditation training has been shown to decrease the reactivity of the amygdala to emotional stimuli also during non-meditative states.

lines 150-152: Overall, there is strong evidence of the structural and functional changes in the brain following mindfulness meditation in numerous conditions, including chronic pain, a widely studied condition of central sensitization.

COMMENT:

The study included 360 participants. Dose participant heterogeneity have an impact on the results. For example, age/gender?

REPONSE:

Thank you for the possibility to clarify the manuscript on this topic. Please see additions made on lines 287-288:

We will perform a modifier analysis on baseline characteristics that may influence outcome impact.

The Discussion already states the following on lines 391-393:

Having enough patients and randomizing them to the different study arms aims at reducing the effect of possible baseline confounding factors.

COMMENT:

The framework of the paper needs to be readjusted. The discussion part is the fifth part, but there are no 1-4 in the manuscript.

RESPONSE:

Thank you for noticing this error. We have removed ‘5.’ from the ‘Discussion’ section.

COMMENT:

Additionally, the paper lack results section.

RESPONSE:

Please see line 332-334:

We have added the following on line 332: ‘The trial is still ongoing.’

Attachments
Attachment
Submitted filename: Response to reviewers.docx
Decision Letter - Dahua Yu, Editor

Effectiveness of mindfulness-based online therapy or internet-delivered cognitive behavioral therapy compared to treatment as usual among patients with persistent somatic symptoms: Protocol for a randomized controlled trial

PONE-D-23-36707R1

Dear Dr. Vangelova-Korpinen,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Dahua Yu

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: All comments have been adequately addressed.

Reviewer #2: I have no suggestions for the revised manuscript, and the current version of manuscript can be accepted.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

Formally Accepted
Acceptance Letter - Dahua Yu, Editor

PONE-D-23-36707R1

PLOS ONE

Dear Dr. Vangelova-Korpinen,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Dahua Yu

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .